期刊文献+

b-FGF在非小细胞肺癌的表达及与肿瘤血管形成和淋巴结转移关系的研究 被引量:3

Expressions of b-FGF in human non-small cell lung cancer and its clinicopathological significance
下载PDF
导出
摘要 目的 :研究碱性成纤维细胞生长因子 (b FGF)在非小细胞肺癌 (NSCLC)中的表达及其生物学意义 ,并探讨其与肿瘤血管形成和淋巴结转移的关系。 方法 :用免疫组化染色技术对 95例NSCLC石蜡组织标本的b FGF及肿瘤内微血管密度 (IMVD)进行检测和分析。 结果 :b FGF在肿瘤细胞阳性表达率明显高于癌旁的正常肺组织 (P <0 .0 5 )。b FGF阳性表达癌组织中的IMVD高于阴性表达癌组织中的IMVD(P <0 .0 5 )。b FGF表达与TNM分期和淋巴结转移有关 (P <0 .0 5 ) ,与组织学分型和肿瘤病理分级无关 (P >0 .0 5 )。 结论 :b FGF可能参与NSCLC的新血管生成并促进肿瘤转移 ;b Objectives:To investigate the expression and distribution of b FGF in human non small cell lung cancer (NSCLC),and to evaluate the relationship between the expression of b FGF and the biological behavior of NSCLC, especially tumor angiogenesis and lymph node metastasis. Methods:The expression of b FGF and IMVD in 95 patients with NSCLC was examined using immunohistochemical methods (SP), and the relationship between the expression and many clinicopathological parameters were analyzed. Results: The positive rates of b FGF in carcinoma tissue (NSCLC) were much higher than those in the normal lung tissues nearby ( P <0.05). The positive expression of b FGF was associated with IMVD , lymph node metastases , and TNM stage of NSCLC( P <0.05),and the expression was not related to the histological subtype and pathological grade ( P >0.05). Conclusions: b FGF may play an important role in tumor angiogenesis and lymphatic metastasis of human NSCLC , and detection of b FGF may be a good metastasis and prognostic predictors for human NSCLC.
出处 《医学研究生学报》 CAS 2003年第4期248-250,共3页 Journal of Medical Postgraduates
基金 南京军区南京总医院科研基金资助项目 (批准号 :2 0 0 2 0 3 8)
关键词 碱性成纤维细胞生长因子 免疫组化 非小细胞肺癌 血管形成 淋巴结转移 Basic fibroblast growth factor Immunohistochemistry Non small cell lung cancer Angiogenesis Lymph node metastasis
  • 相关文献

参考文献8

  • 1秦艳芳,向军俭,杨红宇.碱性成纤维细胞生长因子与肿瘤[J].国外医学(肿瘤学分册),2001,28(4):256-259. 被引量:28
  • 2Fontanini G, Vignati S, Bigini D, et al. Neoangiogenesis: a putative marker of malignancy in non-small-cell lung cancer(NSCLC) development [J]. Int J Cancer,1996, 67(3):615-619. 被引量:1
  • 3Weiderner N. Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow [J]. J pathol, 1998, 184(1): 119-122. 被引量:1
  • 4Weiderner N. Intratumor nicrovessel density as a prognostic factor in cancer [J].Am J Pathal,1995,147(1):9-19 被引量:1
  • 5Hanahan D, Folkman J. Patterns and emerging mwchanisms of the angiogenic seich during tumorigenesis [J].Cell, 1996,86(3):353-364. 被引量:1
  • 6Cox JG,Jones L , Walker RX, et al.Angiogenesis and non-small cell lung cancer [J]. Lung Cancer ,2000 ,27(1): 81-100. 被引量:1
  • 7Takanami I, Tanaka F, Hashizume T,et al. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival[J]. Nepplasma,1997,44(5):295-298. 被引量:1
  • 8Miyake H, Hara I, Gohji K,et al. Exoression of basic fibroblast growth factor is associated with resistance to cisplatin in a human blader cancer line [J]. Cancer Lett,1998,123(2):121-126. 被引量:1

二级参考文献1

  • 1Mai Nguyen. Angiogenic factors as tumor markers[J] 1997,Investigational New Drugs(1):29~37 被引量:1

共引文献27

同被引文献52

  • 1张园,邱健.组织因子及其非凝血功能的研究进展[J].医学研究生学报,2005,18(7):632-635. 被引量:5
  • 2[1]Ziche M,Morbidel L, Choudhuri R et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor induced but not basic fibroblast growth factor induced angiogenesis[J]. J Clin Invest, 1997, 99(8):2625-2634. 被引量:1
  • 3[2]Babaei S,Kuliszewska KT, Monge JC et al.Role of nitric oxide in the angiogenic response in vitro to bastic fibroblast growth factor[J]. Circ Res,1998, 82(9):1007-1015. 被引量:1
  • 4[5]Weiderner N. Intratumor nicrovessel density as a prognostic factor in cancer [J].Am J Pathal,1995,147(1):9-19. 被引量:1
  • 5[6]Gendan JC, Topping KC, Pruitt J et al. Inflammatory mediators stimulate arginine transport and arginine derived nitric oxide production in a murine breast cancer cell line[J]. J Surg Res, 1996, 60(3):284-288. 被引量:1
  • 6[7]Fontanini G, Vignati S, Bigini D et al. Neoangiogenesis: a putative marker of malignancy in non-small-cell lung cancer(NSCLC) development[J]. Int J Cancer,1996, 67(4):615-619. 被引量:1
  • 7[8]Cheon KT, Choi KH, Lee HB et al. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer[J]. Lung,2000,178(6):351-360 . 被引量:1
  • 8[11]Liu CY, Wang CH, Chen HC et al, Increased level of exhaled nitric oxide and up-regualtion of inducible nitric oxide synthase in patients with primary lung cancer[J]. Br J Cancer,1998,78(4):534-541. 被引量:1
  • 9[13]Weiderner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow [J]. J Pathol,1998, 184(1):119-122. 被引量:1
  • 10Bavendiek U,Libby P,Kilbride M,et al.Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B,and Egr-1. 被引量:1

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部